FDA recall record

Qualitest Pharmaceuticals Disulfiram tablets, USP, 500 mg, 100-count bottles recall — FDA D1151-2015

Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product lot was found to be out of specification for…

Class IIIclassification
D1151-2015official record ID
Jul 8, 2015report date

Recall record at a glance

Official recordD1151-2015
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmQualitest Pharmaceuticals
Report dateJul 8, 2015
Recall initiation dateJun 18, 2015
Quantity2016 bottles
LocationHuntsville, AL, United States

Official product description

Disulfiram tablets, USP, 500 mg, 100-count bottles, Rx only, Manufactured for and by Qualitest Pharmaceuticals 130 Vintage Drive Huntsville, AL 35811. NDC 0603-3432-21.

Why the product was recalled

Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product lot was found to be out of specification for dissolution.

Distribution information

Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.